Efficacy of PD-1/PD-L1 inhibitors combined with multi-targeted anti-angiogenic TKIs in advanced or metastatic NSCLC: A meta-analysis based on RCTs

BackgroundThe efficacy of combining programmed cell death protein-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors with multi-targeted anti-angiogenic tyrosine kinase inhibitors (TKIs) in advanced or metastatic non-small cell lung cancer (NSCLC) remains controversial. This study therefore aimed...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zeqi Tang, Xiaoming Zhang, Zhanqi Sun, Shiyan Zhang, Xiaoling Feng, Yixia Chen, Haiqi Xu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-04-01
Edice:	Frontiers in Oncology
Témata:	meta-analysis multi-targeted anti-angiogenic TKIs NSCLC os PD-1/PD-L1 inhibitors PFS
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1799126/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!